Rebus Holdings Inc Sustainability Reports
Rebus Holdings, Inc. is a pharmaceutical company that focuses on the research and development of precision therapeutics and novel targeted treatments for cancer.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
LEI: 549300SP05MV2KS7BN88
FIGI: BBG001T5LJ63
No reports are currently available in our catalogue.